Depreciation in USD of Sonnet BioTherapeutics Holdings, Inc. from Q2 2011 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly and annual Depreciation history and change rate from Q2 2011 to Q4 2024.
  • Sonnet BioTherapeutics Holdings, Inc. Depreciation for the quarter ending 31 Dec 2024 was $3,211, unchanged year-over-year.
  • Sonnet BioTherapeutics Holdings, Inc. annual Depreciation for 2024 was $12,843, a 0.02% decline from 2023.
  • Sonnet BioTherapeutics Holdings, Inc. annual Depreciation for 2023 was $12,845, unchanged from 2022.
  • Sonnet BioTherapeutics Holdings, Inc. annual Depreciation for 2022 was $12,845, a 3.12% increase from 2021.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Sonnet BioTherapeutics Holdings, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $3,211 $0 0% 01 Oct 2024 31 Dec 2024 10-Q 13 Feb 2025 2024 Q1
Q4 2023 $3,211 $0 0% 01 Oct 2023 31 Dec 2023 10-Q 13 Feb 2025 2024 Q1
Q4 2022 $3,211 -$1 -0.03% 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024 2024 Q1
Q4 2021 $3,212 +$131 +4.3% 01 Oct 2021 31 Dec 2021 10-Q 13 Feb 2023 2023 Q1
Q4 2020 $3,081 01 Oct 2020 31 Dec 2020 10-Q 08 Feb 2022 2022 Q1
Q3 2019 $1,680,943 $419,000 -$18,000 -4.1% 01 Jul 2019 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $1,698,943 $432,000 +$40,000 +10% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $1,658,943 $423,000 +$16,000 +3.9% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 $1,642,943 $406,943 01 Oct 2018 31 Dec 2018 10-K 01 Apr 2019 2018 FY
Q3 2018 $437,000 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2019 Q3
Q2 2018 $392,000 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019 2019 Q2
Q1 2018 $407,000 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q2 2015 $376,140 -$197,623 -34% 01 Apr 2015 30 Jun 2015 10-Q 14 Aug 2015 2015 Q2
Q2 2014 $573,763 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015 2015 Q2
Q3 2013 $123,754 +$30,997 +33% 01 Jul 2013 30 Sep 2013 10-Q 15 Nov 2013 2013 Q3
Q1 2013 $56,981 $124,478 +$48,213 +63% 01 Jan 2013 31 Mar 2013 10-Q 12 Aug 2013 2013 Q2
Q4 2012 $8,768 $-242,923 01 Oct 2012 31 Dec 2012 10-K 31 Mar 2014 2013 FY
Q3 2012 $92,757 +$90,245 +3,593% 01 Jul 2012 30 Sep 2012 10-Q 15 Nov 2013 2013 Q3
Q2 2012 $82,669 +$80,157 +3,191% 01 Apr 2012 30 Jun 2012 10-Q 12 Aug 2013 2013 Q2
Q1 2012 $76,265 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013 2013 Q1
Q3 2011 $2,512 01 Jul 2011 30 Sep 2011 10-Q/A 31 Dec 2012 2012 Q3
Q2 2011 $2,512 01 Apr 2011 30 Jun 2011 10-Q/A 02 Jan 2013 2012 Q2

Sonnet BioTherapeutics Holdings, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $12,843 -$2 -0.02% 01 Oct 2023 30 Sep 2024 10-K 17 Dec 2024 2024 FY
2023 $12,845 $0 0% 01 Oct 2022 30 Sep 2023 10-K 17 Dec 2024 2024 FY
2022 $12,845 +$389 +3.1% 01 Oct 2021 30 Sep 2022 10-K 14 Dec 2023 2023 FY
2021 $12,456 +$4,162 +50% 01 Oct 2020 30 Sep 2021 10-K 15 Dec 2022 2022 FY
2020 $8,294 01 Oct 2019 30 Sep 2020 10-K 17 Dec 2021 2021 FY
2018 $1,642,943 -$307,078 -16% 01 Jan 2018 31 Dec 2018 10-K 01 Apr 2019 2018 FY
2017 $1,950,021 01 Jan 2017 31 Dec 2017 10-K 01 Apr 2019 2018 FY
2013 $6,797 -$1,971 -22% 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2014 2013 FY
2012 $8,768 -$65,470 -88% 01 Jan 2012 31 Dec 2012 10-K 31 Mar 2014 2013 FY
2011 $74,238 01 Jan 2011 31 Dec 2011 10-K 03 Apr 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.